Clinical Trial Update: Lactobacillus Acidophilus L92 on Markers of Allergic Inflammation by Nasal Provocation With Grass Pollen [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Lactobacillus acidophilus L92 for markers of allergic inflammation in response to grass pollen for hay fever was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hay Fever
• Seasonal Allergic Rhinitis

Drugs mentioned

• Lactobacillus acidophilus L92 (Lactobacillus acidophilus L92)

Snippet

Sponsor: University of California, Davis | Conditions: Hayfever | Phase 3 | Status: WITHDRAWN